Literature DB >> 31000004

Translating Cardioprotection for Patient Benefit: The EU-CARDIOPROTECTION COST Action.

Derek J Hausenloy1, Gerd Heusch2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31000004     DOI： 10.1016/j.jacc.2019.03.020

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  CAESAR's legacy: a new era of rigor in preclinical studies of cardioprotection.

Authors:  Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2021-05-20       Impact factor: 17.165

Review 2.  Perioperative Cardioprotection by Remote Ischemic Conditioning.

Authors:  Youn Joung Cho; Won Ho Kim
Journal:  Int J Mol Sci       Date:  2019-09-29       Impact factor: 5.923

Review 3.  IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action.

Authors:  Sandrine Lecour; Ioanna Andreadou; Péter Ferdinandy; Derek J Hausenloy; Hans Erik Bøtker; Sean M Davidson; Gerd Heusch; Marisol Ruiz-Meana; Rainer Schulz; Coert J Zuurbier
Journal:  Basic Res Cardiol       Date:  2021-09-13       Impact factor: 17.165

4.  The platelet paradox of injury versus protection in myocardial infarction-has it been overlooked?

Authors:  Petra Kleinbongard; Ioanna Andreadou; Gemma Vilahur
Journal:  Basic Res Cardiol       Date:  2021-05-26       Impact factor: 17.165
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.